Concepedia

Author

M. Jansen

Octapharma (Austria)ORCID

Also Known As

M. JANSEN, M. Jansen, M. R. Jansen, M.R. Jansen, Marnix Jansen, Marnix R. Jansen

39

Publications

228

Citations

8

H-Index

9

Concepts

All Affiliations

Octapharma (Austria)Medical University of WarsawOctapharma (Switzerland)University College LondonGreat Ormond Street Hospital
MJ

About

M. Jansen is an author at Octapharma (Austria) specializing in pediatrics, maternal health, and sepsis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

16

2

Public Health

1

1

16

3

Hematology

1

1

16

4

Cardiovascular Disease

1

1

16

5

Maternal Health

1

1

16

M. Jansen

×

8

Publications

200

Citations

8

H-Index

YearCitations

First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study

W. Kreuz, Carmen Escuriola Ettingshausen, Vladimír Vdovin,

Haemophilia

2015

56

Novel, human cell line‐derived recombinant factor <scp>VIII</scp> (Human‐cl rh<scp>FVIII</scp>, Nuwiq<sup>®</sup>) in children with severe haemophilia A: efficacy, safety and pharmacokinetics

Anna Klukowska, Tomasz Szczepański, Vladimír Vdovin,

Haemophilia

2015

44

Immunogenicity, efficacy and safety of Nuwiq<sup>®</sup> (human‐cl rh<scp>FVIII</scp>) in previously untreated patients with severe haemophilia A—Interim results from the NuProtect Study

Ri Liesner, Marina Abashidze, Olga Aleinikova,

Haemophilia

2017

27

Low incidence of factor VIII inhibitors in previously untreated patients during prophylaxis, on-demand treatment and surgical procedures, with Octanate®: interim report from an ongoing prospective clinical study

Anna Klukowska, V. Komrska, M. Jansen

Haemophilia

2010

20

Efficacy and safety of Wilate in paediatric VWD patients under 6 years of age - results of a prospective multicentre clinical study including recovery information

Ulrike Nowak‐Göttl, Anne Krümpel, Alexandra Russo,

Haemophilia

2013

16

Long‐term tolerability, immunogenicity and efficacy of Nuwiq<sup>®</sup> (human‐cl rhFVIII) in children with severe haemophilia A

Anna Klukowska, Tomasz Szczepański, Vladimír Vdovin,

Haemophilia

2018

14

The Need for Routine Native Nephrectomy in the Workup for Kidney Transplantation in Autosomal Dominant Polycystic Kidney Disease Patients

Niek F. Casteleijn, Paul Geertsema, Iris W. Koorevaar,

Urologia Internationalis

2022

13

Efficacy and safety of Nuwiq<sup>®</sup> (human‐cl rh<scp>FVIII</scp>) in patients with severe haemophilia A undergoing surgical procedures

N. I. Zozulya, Craig M. Kessler, Anna Klukowska,

Haemophilia

2017

10

Page 1